PEGylated PAMAM dendrimers: Enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery
Abstract Poly (amidoamine) dendrimers (PAMAM) are well-defined, highly branched,
nanoscale macromolecules with numerous active amine groups on the surface. PAMAM …
nanoscale macromolecules with numerous active amine groups on the surface. PAMAM …
Effect of 2nd and 3rd generation PAMAM dendrimers on proliferation, differentiation, and pro-inflammatory cytokines in human keratinocytes and fibroblasts
R Czarnomysy, A Bielawska… - International Journal of …, 2019 - Taylor & Francis
Background Poly (amidoamine)(PAMAM) dendrimers are of considerable interest when
used as a carrier for topical drugs for the skin, although little is known about their possible …
used as a carrier for topical drugs for the skin, although little is known about their possible …
[HTML][HTML] Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
Approximately 20% of breast cancer cases are human epidermal growth factor receptor 2
(HER2)-positive. This type of breast cancer is more aggressive and tends to reoccur more …
(HER2)-positive. This type of breast cancer is more aggressive and tends to reoccur more …
PAMAM dendrimer based targeted nano-carrier for bio-imaging and therapeutic agents
In the last several decades, researchers have focused on developing suitable drug carriers
to deliver pharmaceutical agents to treat cancer diseases. PAMAM dendrimers have been …
to deliver pharmaceutical agents to treat cancer diseases. PAMAM dendrimers have been …
[HTML][HTML] Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells
S Khatri, NG Das, SK Das - Journal of Pharmacy and Bioallied …, 2014 - journals.lww.com
The aim of this work was to synthesize methotrexate (MTX)-polyamidoamine (PAMAM)
dendritic nanoconjugates and to study their effect on cell viability in uterine sarcoma cells …
dendritic nanoconjugates and to study their effect on cell viability in uterine sarcoma cells …
Dendrimer mediated targeting of siRNA against polo‐like kinase for the treatment of triple negative breast cancer
A Jain, S Mahira, JP Majoral… - … Research Part A, 2019 - Wiley Online Library
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …
Gadobutrol-dendrimer effects on metastatic and apoptotic gene expression
A Kebriaezadeh, S Ashrafi, R Rasouli… - Advances in nano …, 2016 - techno-press.org
Dendrimers are one of the most appropriate nanocaries for imaging moieties in imaging
applications. The purpose of this study was the evalution of cytotoxicity and inducing …
applications. The purpose of this study was the evalution of cytotoxicity and inducing …
Herniarin-loaded solid lipid nanoparticles: promising molecular mechanism and therapeutic potential against pancreatic cancer line
AMD Delkhah, E Karimi, S Farivar - Molecular Biology Reports, 2023 - Springer
Background The notion of cancer therapy is intrinsically subjected to multiple challenges
due to the drug resistance and drug toxicity for normal tissues. Herniarin (7 …
due to the drug resistance and drug toxicity for normal tissues. Herniarin (7 …
Synthesis, dynamics and applications (cytotoxicity and biocompatibility) of dendrimers: A mini-review
Dendrimers are an excellent candidate that exhibits higher proficiency in biomedical
applications such as drug delivery, inhibition and/or targeting gene delivery. The use of …
applications such as drug delivery, inhibition and/or targeting gene delivery. The use of …
[HTML][HTML] Nanostructured dihydroartemisinin plus epirubicin liposomes enhance treatment efficacy of breast cancer by inducing autophagy and apoptosis
The heterogeneity of breast cancer and the development of drug resistance are the relapse
reasons of disease after chemotherapy. To address this issue, a combined therapeutic …
reasons of disease after chemotherapy. To address this issue, a combined therapeutic …